Download Free Medical Metastasis PowerPoint Presentation

Metastasis PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Breast Cancer (Inflammatory), which is titled "Metastasis", to know about metastasis, the truly lethal event in cancer we know least about.

Tags : Breast Cancer, Inflammatory, Metastasis

Published on : May 10, 2021 | Views : 2231 | Downloads : 3

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Metastasis
Slide 2-

Hanahan and Weinberg: the hallmarks of cancer Cell 100: 57-70 2000 Hallmarks of cancer
Slide 3-

Mutations in the cancer cell
Slide 4-

What is metastasis? Tumors take many years before detection (>109 cells)- particularly if tumor growing in an extensible space. Only when tumor begins to compromise function of the organ does it evoke symptoms. Most primary tumors can be surgically excised and account for less than 10% of cancer deaths. For 90% of patients - primary successfully excised but patients die as a result of disease at sites distant to that of primary. Metastasis is the truly lethal event in cancer but also the process we know least about. Understanding metastasis has the greatest potential to extend patient survival.
Slide 5-

ppt slide no 5 content not found
Slide 6-

ppt slide no 6 content not found
Slide 7-

ppt slide no 7 content not found
Slide 8-

ppt slide no 8 content not found
Slide 9-

ppt slide no 9 content not found
Slide 10-

ppt slide no 10 content not found
Slide 11-

Metastatic disease non Hodgkins Lymphoma (NHL): -CT scan (blue) -PET scan (yellow) – FDG accumulates in regions active metabolism
Slide 12-

Tumor cells metastasize through lymph and blood vessels Pancreatic cancer cells within lymphatic vessel Breast cancer in lymphatic drainage
Slide 13-

Metastases disrupt organ functions Breast cancer metastasizes to bone (pain and skeletal collapse); brain, lungs, liver (function). Other cancers spread to different organs. Some cancers have very high rates of metastasis-while others hardly metastasize at all. Understanding the basis for these differences could lead to control over tumor spread.
Slide 14-

Size of primary correlates with risk of breast cancer metastasis 1589 tumors followed for up to 46 years.
Slide 15-

If larger tumors associated with increased risk of metastasis then is metastasis a late event (mutations in metastasis genes)? Simplistic deduction: Since 4% breast cancers under 1 cm ~ mutant p53 alleles. And 42% breast cancers over 3 cm ~ mutant p53 cancers acquire further mutations as they grow. Mutations that favor metastasis may therefore arise as late events. Just as likely: a) Cells in large and small tumors equally capable of metastasizing but large tumors seed more cells b) Large tumors contain more proliferative cells and mutations that influence proliferation influence metastasis. Difficult to predict when metastasis first occurs.
Slide 16-

If the metastatic phenotype arises early then most tumors will have already metastasized by the time of detection Consensus: most tumors do metastasize early and give rise to micrometastases that are too small to detect. Aggressive therapy given soon after detection of primary may therefore reduce the incidence of metastatic disease.
Slide 17-

How do tumors spread? The concept of the invasion-metastasis cascade: 6 distinct steps Probability of an individual cancer cell completing cascade is very small
Slide 18-

Step 1: Invasion Invasive lobular mammary carcinoma progressing in single file from left to right through channels they have carved in stroma
Slide 19-

More typically cells invade as a posse Melanoma cells moving as a cohort through collagen matrix. Adherens junctions red (E-cadherin). b1 integrins metalloproteinases
Slide 20-

Breach of basement membrane Inflammatory cells Basement membrane Squamous carcinoma
Slide 21-

Step 2 Intravasation: transport thro vasculature Hazards: Anoikis (homelessness)- loss of substrate contact-triggers apoptosis. Shear forces. Lack of stromal support (survival factors). Exposure to cells of the immune system. Exposure to platelets (beneficial).
Slide 22-

Routes of circulation Tumors usually lodge in first capillary bed they encounter Tumors that attract platelets ~ may lodge in wider vessels such as arteriole
Slide 23-

Step 3: extravasation vessel tumor clump
Slide 24-

Tumors attach to vessel walls thro microthrombi Localized exposure of basement membrane provides attachment points for potential microthrombi attachment red blood cells platelets
Slide 25-

Tumors stimulate microthrombi Within seconds of entering blood stream tumors stimulate thrombus formation (platelets and red blood cells). Tissue factor activates thrombin and converts fibrinogen to fibrin. Mice lacking platelets (Nf-E2-) do not support metastasis of malignant melanoma C and D. Tumor cell platelet
Slide 26-

How efficient is metastasis? Mice carrying primary tumors of 1 gm (109 cells) 106 cells enter circulation per day. However less than 5 tumors result. Metastatic inefficiency.
Slide 27-

Step 4: colonization Colonization - the rate-limiting step. Unlike the primary tumor tissues lack stroma that provide support. Consequently most micrometastases remain dormant for long periods or die before they can give rise to 2ndary tumors.
Slide 28-

Evolution of metastatic ability can occur outside the primary tumor
Slide 29-

The evolution of colonizing ability
Slide 30-

Micrometastases (MM) detectable in bone marrow Micrometastasis of: A. colon cancer B. breast cancer in bone-marrow detected using anti-cytokeratin antibodies 1% normal have +ve cells cf 36% breast cancer (stage I, II, III). 1 colony per 105 to 106 mesenchymal cells A B
Slide 31-

Does marrow micrometastasis predict relapse? Patients with MM at time of surgery have higher relapse rates. Breast cancer MM increase risk of developing metastatic disease 4 to 10 fold. Colon cancer patients 90% patients who lack MM alive at 15 months compared to 30% of those with marrow MM Cancer esophagus – 79-88% pts have MM in rib marrow at resection
Slide 32-

Can MM remain dormant? Are MM truly dormant? Fluorescently-labeled cells lose fluorescence with each division. Breast cancer cells injected into portal vein lodge in liver were viable and had not lost fluorescence 11 weeks later. Cells could be excised, cultured and retained tumorigenicity when introduced subcutaneously. Cells were resistant to chemotherapy that killed growing cells.
Slide 33-

What we have learned so far Invasion-metastasis cascade has multiple steps. As many changes in phenotype involved as precede inititial tumor formation. Cells readily enter circulation and seed distant sites. However, only a small fraction grow. Nevertheless vast numbers of cells seeded by growing tumors ensure that some of these will eventually grow. Clinically these pose a major threat to survival of patient. Important question: To what extent do the steps represent changes in gene expression. Are there metastasis specific genes and their suppressors?
Slide 34-

Epithelial-mesenchymal transition (a wolf in sheep’s clothing) Migration and motility require epithelial cells to lose their differentiated adhesive nature and become mesenchyme-like.
Slide 35-

EMT Upper panel: Epithelial cells in monolayer culture exposed to metalloproteinase MMP-3. Cells lose cytokeratins (red) and E-cadherin and acquire vimentin (green) fibronectin and N-cadherin become motile and invasive. Become indistinguishable from mesenchyme. Lower panel: Wounding MCF10A (pre-malignant) monolayer –induction of vimentin (red) at wound site. Vimentin lost once cells revert to epithelial.
Slide 36-

Embryogenesis and EMT Ectodermal-mesodermal transition at gastrulation Delamination neuroepithelial cells from neural tube to form melanocytes, peripheral NS
Slide 37-

Can we see EMT in tumors? Loss of E-cadherin (brown) from membrane of cells at invasive edge of colon carcinoma (arrows)
Slide 38-

ppt slide no 38 content not found
Slide 39-

b-catenin translocates to nuclei
Slide 40-

Biochemical changes accompanying EMT Expressing Twist transcription factor in MDCK cells induces fibronectin and vimentin
Slide 41-

Confirmation by immunoblot
Slide 42-

E cadherin N-cadherin switch plays a pivotal role in EMT E-cadherin to N-cadherin switch permits new associations with mesenchymal cells. Similarly gastrulation as well as HGF embryonic ectodermal layer—emigration and dermal precursors from primitive dermomyotome. Homotypic interactions permit invasion into and establishment of epithelial cells in mesenchyme. N-cadherin bonds weaker than E-cadherin.
Slide 43-

HGF (stromal factor) induces scattering in MDCK cells
Slide 44-

EMT induced by stromal signals and therefore reversible
Slide 45-

Why do 2ndary tumors resemble primary tumors and not mesenchyme? Reversibility may be the key Histopathology of primary and secondary tumors often strikingly similar. In fact used by pathologists to Identify tumors of unknown origin and b) Dismiss the concept of EMT!
Slide 46-

Exposing the wolf Mouse stroma Human vimentin EMT at invasive edge of human mammary epithelial cells in mouse host.
Slide 47-

How do stromal cells control EMT? Role of TGF-b
Slide 48-

Macrophages: role in invasion and metastasis +/op mice make CSF1 and recruit macrophages to tumors-mets form in lungs op/op mice lack CSF1 and cannot recruit macrophages- mets do not form in lungs
Slide 49-

ppt slide no 49 content not found
Slide 50-

Signals that trigger EMT
Slide 51-

Embryonic transcription factors programming EMT
Slide 52-

Transient expression Slug in wound healing Monolayer of keratinocytes scraped to induce wound
Slide 53-

Expression EMT-inducing transcription factors in tumors Slug binds to E-box sequence in E-cad promoter
Slide 54-

Similarities between EMT embryogenesis and tumor progression
Slide 55-

Extracellular proteases and invasiveness collagen IV cleavage (inhibited by MMP inhibitors) fibroblasts Mammary carcinoma in MMTV-polyoma middle T mouse proteolysis
Slide 56-

Podosomes and focal degradation of ECM (MT1-MMP) Actin (red) FITC - fibronectin (green) Degradation fibronectin (black) Colocalization podosome and degradation (arrow)
Slide 57-

Protease cascade induced by stroma
Slide 58-

Rho-C and metastasis (epithelial morphology) (fibroblast morphology)
Slide 59-

Metastatic dissemination via lymphatics
Slide 60-

Metastatic tropisms-seed and soil or hydrodynamics?
Slide 61-

Colorectal cell metastasis: a matter of drainage
Slide 62-

Metastasis to bone (osteotropic metastasis) requires the subversion of osteoblasts and osteoclasts Osteoclasts (arrowed) excavating jaw bone
Slide 63-

Vicious cycle of osteoclast metastasis Parathyroid hormone-related peptide
Slide 64-

Are there metastasis genes?
Slide 65-

ppt slide no 65 content not found
Slide 66-

ppt slide no 66 content not found
Slide 67-

ppt slide no 67 content not found